Yihai Liu
Overview
Explore the profile of Yihai Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen S, Li J, Wei Z, Liu Y, Kang L, Gu R, et al.
Biol Direct
. 2024 Oct;
19(1):86.
PMID: 39350193
The immune response gene 1 (IRG1) and its metabolite itaconate are implicated in modulating inflammation and oxidative stress, with potential relevance to sepsis-induced myocardial dysfunction (SIMD). This study investigates their...
2.
Gong C, Chang L, Huang R, Sun X, Liu Y, Wu S, et al.
Pharmacol Res
. 2024 Aug;
208:107347.
PMID: 39153710
Ischemic heart failure rates rise despite decreased acute myocardial infarction (MI) mortality. Excessive myofibroblast activation post-MI leads to adverse remodeling. LIM kinases (LIMK1 and LIMK2) regulate cytoskeleton homeostasis and are...
3.
Zhong C, Bai J, Qu X, Liu Y, Li Z, Hao H, et al.
Heliyon
. 2024 May;
10(10):e30992.
PMID: 38818187
Background: The effects of metformin on atrial fibrillation (AF) in type 2 diabetes patients remain unclear. We aimed to explore the effects of metformin on AF, including new-onset AF and...
4.
Chen B, Fu W, Jie C, Zhang G, Li Z, Liu Y, et al.
Mol Med Rep
. 2024 May;
30(1).
PMID: 38757339
During osteoarthritis (OA), chondrocytes become highly active, with increased matrix synthesis and inflammatory cytokine‑induced catabolic pathways. Early intervention strategies targeting pathological changes may attenuate or halt disease progression. The present...
5.
Liu Y, Zhong C, Chen S, Xue Y, Wei Z, Dong L, et al.
Cardiovasc Diabetol
. 2024 Feb;
23(1):60.
PMID: 38336726
Background: Coronary microvascular dysfunction (CMD) is a frequent complication of diabetes mellitus (DM) characterized by challenges in both diagnosis and intervention. Circulating levels of microRNAs are increasingly recognized as potential...
6.
Si J, Kang L, Liu Y
Endocr Metab Immune Disord Drug Targets
. 2024 Jan;
24(12):1395-1400.
PMID: 38173063
Objectives: The body fat percentage is an indicator of overall body fat related to metabolism and inflammation. Our study aims to analyze the association between body fat percentage and the...
7.
Jiang C, Shi Q, Yang J, Ren H, Zhang L, Chen S, et al.
J Adv Res
. 2023 Oct;
63:159-170.
PMID: 37871772
Introduction: Sepsis-induced cardiac injury is the leading cause of death in patients. Recent studies have reported that reactive oxygen species (ROS)-mediated ferroptosis and macrophage-induced inflammation are the two main key...
8.
Wu M, Si J, Liu Y, Kang L, Xu B
Clin Exp Hypertens
. 2023 Jul;
45(1):2233712.
PMID: 37439538
Aim: The association between composite dietary antioxidant index (CDAI) and hypertension remains unknown. Our study was to investigate the association of CDAI with hypertension in general adults. Methods: A total...
9.
Wu M, Liao S, Si J, Guo X, Kang L, Xu B, et al.
Diabetes Metab Syndr
. 2023 May;
17(6):102784.
PMID: 37216854
Aims: To explore the association between low-density lipoprotein-cholesterol (LDL-C) and all-cause and cause-specific mortality based on a prospective cohort study. Methods: Among 10850 individuals enrolled from National Health and Nutrition...
10.
Liu Y, Chang L, Wu M, Xu B, Kang L
Angiology
. 2022 Oct;
74(3):298.
PMID: 36225149
No abstract available.